These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA. Kreek MJ; Schlussman SD; Bart G; Laforge KS; Butelman ER Neuropharmacology; 2004; 47 Suppl 1():324-44. PubMed ID: 15464148 [TBL] [Abstract][Full Text] [Related]
3. Neurobiology of addictive behaviors and its relationship to methadone maintenance. Stimmel B; Kreek MJ Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487 [TBL] [Abstract][Full Text] [Related]
5. [Psychopharmacological models of drug dependence. Key role of the dopaminergic mesolimbic system]. Wallnöfer A Schweiz Rundsch Med Prax; 1993 Sep; 82(37):999-1003. PubMed ID: 8210861 [TBL] [Abstract][Full Text] [Related]
7. The role of the endogenous cannabinoid system in drug addiction. Parolaro D; Rubino T Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613 [TBL] [Abstract][Full Text] [Related]
8. Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Kreek MJ Neurochem Res; 1996 Nov; 21(11):1469-88. PubMed ID: 8947936 [TBL] [Abstract][Full Text] [Related]
9. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. Potvin S; Stip E; Roy JY Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543 [TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Cunha-Oliveira T; Rego AC; Oliveira CR Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072 [TBL] [Abstract][Full Text] [Related]
11. Addictive drugs and their relationship with infectious diseases. Friedman H; Pross S; Klein TW FEMS Immunol Med Microbiol; 2006 Aug; 47(3):330-42. PubMed ID: 16872369 [TBL] [Abstract][Full Text] [Related]
13. A cell biologist's perspective on physiological adaptation to opiate drugs. von Zastrow M Neuropharmacology; 2004; 47 Suppl 1():286-92. PubMed ID: 15464144 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726 [TBL] [Abstract][Full Text] [Related]
15. [Individual susceptibility to addiction. Contribution of animal models]. Henry C; Le Moal M; Bourgeois M Encephale; 1994; 20(1):1-6. PubMed ID: 8174505 [TBL] [Abstract][Full Text] [Related]
16. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Sinha R; Garcia M; Paliwal P; Kreek MJ; Rounsaville BJ Arch Gen Psychiatry; 2006 Mar; 63(3):324-31. PubMed ID: 16520439 [TBL] [Abstract][Full Text] [Related]
18. Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness. Molina PE J Intern Med; 2006 Feb; 259(2):138-54. PubMed ID: 16420543 [TBL] [Abstract][Full Text] [Related]
19. Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology. Eisch AJ; Harburg GC Hippocampus; 2006; 16(3):271-86. PubMed ID: 16411230 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Manchikanti L; Singh A Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]